{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T18:52:18Z","timestamp":1785783138658,"version":"3.56.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpurol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric Urology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jpurol.2025.01.015","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T04:54:44Z","timestamp":1738040084000},"page":"661-669","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Long-term intravesical oxybutynin for neurogenic bladder in children has good urodynamic and renal outcome"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7924-254X","authenticated-orcid":false,"given":"William","family":"De Smedt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5503-529X","authenticated-orcid":false,"given":"Katrien","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Bogaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jpurol.2025.01.015_bib1","doi-asserted-by":"crossref","DOI":"10.1007\/s00467-007-0691-z","article-title":"The neurogenic bladder: medical treatment","volume":"23","author":"Verpoorten","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jpurol.2025.01.015_bib2","doi-asserted-by":"crossref","unstructured":"S. hong Shen, X. Jia, L. Peng, X. Zeng, H. Shen, and D. yi Luo, \u201cIntravesical oxybutynin therapy for patients with neurogenic detrusor overactivity: a systematic review and meta-analysis,\u201d 2022. doi: 10.1007\/s11255-022-03129-0.","DOI":"10.1007\/s11255-022-03129-0"},{"key":"10.1016\/j.jpurol.2025.01.015_bib3","article-title":"EAU\/ESPU guidelines on the management of neurogenic bladder in children and adolescent part I diagnostics and conservative treatment","author":"Stein","year":"2020","journal-title":"Neurourol Urodyn"},{"issue":"5","key":"10.1016\/j.jpurol.2025.01.015_bib4","doi-asserted-by":"crossref","DOI":"10.1007\/PL00007103","article-title":"Oxybutynin and the overactive bladder","volume":"19","author":"Andersson","year":"2001","journal-title":"World J Urol"},{"issue":"12","key":"10.1016\/j.jpurol.2025.01.015_bib5","doi-asserted-by":"crossref","DOI":"10.4111\/kju.2014.55.12.828","article-title":"Efficacy, tolerability, and safety of oxybutynin chloride in pediatric neurogenic bladder with spinal dysraphism: a retrospective, multicenter, observational study","volume":"55","author":"Lee","year":"2014","journal-title":"Korean J Urol"},{"issue":"3 I","key":"10.1016\/j.jpurol.2025.01.015_bib6","article-title":"Intravesical oxybutynin for neurogenic bladder dysfunction: less systemic side effects due to reduced first pass metabolism","volume":"160","author":"Buyse","year":"1998","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.jpurol.2025.01.015_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.juro.2013.05.011","article-title":"Pharmacokinetics of intravesical versus oral oxybutynin in healthy adults: results of an open label, randomized, prospective clinical study","volume":"190","author":"Krause","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2025.01.015_bib8","doi-asserted-by":"crossref","unstructured":"R. Hall and K. Ward, \u201cBasic understanding of urodynamics,\u201d 2022. doi: 10.1016\/j.ogrm.2022.04.003.","DOI":"10.1016\/j.ogrm.2022.04.003"},{"issue":"6","key":"10.1016\/j.jpurol.2025.01.015_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-5347(01)68230-2","article-title":"Estimating normal bladder capacity in children","volume":"158","author":"Kaefer","year":"1997","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.jpurol.2025.01.015_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/nau.22560","article-title":"Long-term outcome of intravesical oxybutynin in children with detrusor-sphincter dyssynergia: with special reference to age-dependent parameters","volume":"34","author":"Humblet","year":"2015","journal-title":"Neurourol Urodyn"},{"issue":"7","key":"10.1016\/j.jpurol.2025.01.015_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/nau.22783","article-title":"International Children's Continence Society standardization report on urodynamic studies of the lower urinary tract in children","volume":"34","author":"Bauer","year":"2015","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.jpurol.2025.01.015_bib12","doi-asserted-by":"crossref","unstructured":"T. P. V. M. de Jong and A. J. Klijn, \u201cUrodynamic studies in pediatric urology,\u201d 2009. doi: 10.1038\/nrurol.2009.200.","DOI":"10.1038\/nrurol.2009.200"},{"issue":"2","key":"10.1016\/j.jpurol.2025.01.015_bib13","doi-asserted-by":"crossref","DOI":"10.1007\/BF02388714","article-title":"International system of radiographic grading of vesicoureteric reflux","volume":"15","author":"Lebowitz","year":"1985","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.jpurol.2025.01.015_bib14","doi-asserted-by":"crossref","unstructured":"G. Filler, A. Yasin, and M. Medeiros, \u201cMethods of assessing renal function,\u201d 2014. doi: 10.1007\/s00467-013-2426-7.","DOI":"10.1007\/s00467-013-2426-7"},{"issue":"3","key":"10.1016\/j.jpurol.2025.01.015_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.juro.2008.05.056","article-title":"Intravesical oxybutynin for children with poorly compliant neurogenic bladder: a systematic review","volume":"180","author":"Guerra","year":"2008","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.jpurol.2025.01.015_bib16","article-title":"Follow-up of long-time treatment with intravesical oxybutynin for neurogenic bladder in children","volume":"34","author":"Amark","year":"1998","journal-title":"Eur Urol"},{"issue":"11","key":"10.1016\/j.jpurol.2025.01.015_bib17","doi-asserted-by":"crossref","DOI":"10.1007\/s00467-007-0564-5","article-title":"Risk factors for renal scarring in children and adolescents with lower urinary tract dysfunction","volume":"22","author":"Leonardo","year":"2007","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"10.1016\/j.jpurol.2025.01.015_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/nau.22608","article-title":"Diagnostic accuracy of Tc-99m DMSA scintigraphy and renal ultrasonography for detecting renal scarring and relative function in patients with spinal dysraphism","volume":"34","author":"Veenboer","year":"2015","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"10.1016\/j.jpurol.2025.01.015_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-5347(01)65629-5","article-title":"Long-term intravesical oxybutynin chloride therapy in children with myelodysplasia","volume":"156","author":"Painter","year":"1996","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.jpurol.2025.01.015_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.eururo.2005.12.056","article-title":"Early start to therapy preserves kidney function in spina bifida patients","volume":"49","author":"Dik","year":"2006","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.jpurol.2025.01.015_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/nau.22755","article-title":"Efficacy, safety, and tolerability of intravesically administered 0.1% oxybutynin hydrochloride solution in adult patients with neurogenic bladder: a randomized, prospective, controlled multi-center trial","volume":"35","author":"Schr\u00f6der","year":"2016","journal-title":"Neurourol Urodyn"},{"issue":"7","key":"10.1016\/j.jpurol.2025.01.015_bib22","doi-asserted-by":"crossref","DOI":"10.1046\/j.1464-410x.2001.02152.x","article-title":"Side-effects of oral or intravesical oxybutynin chloride in children with spina bifida","volume":"87","author":"Ferrara","year":"2001","journal-title":"BJU Int"},{"issue":"7","key":"10.1016\/j.jpurol.2025.01.015_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/jcph.1809","article-title":"A population pharmacokinetic model of (R)- and (S-) oxybutynin and its active metabolites after oral and intravesical administration to healthy volunteers","volume":"61","author":"Kretschmar","year":"2021","journal-title":"J Clin Pharmacol"}],"container-title":["Journal of Pediatric Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477513125000178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477513125000178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T15:05:46Z","timestamp":1755097546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477513125000178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1477513125000178"],"URL":"https:\/\/doi.org\/10.1016\/j.jpurol.2025.01.015","relation":{},"ISSN":["1477-5131"],"issn-type":[{"value":"1477-5131","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term intravesical oxybutynin for neurogenic bladder in children has good urodynamic and renal outcome","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpurol.2025.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}